Le Lézard
Classified in: Health, Science and technology
Subjects: PER, WOM, DEI

Julie Byerley, M.D. appointed President and Dean of Geisinger Commonwealth School of Medicine, Executive Vice President, Chief Academic Officer


DANVILLE, Pa., Sept. 24, 2021 /PRNewswire/ -- Geisinger announced that Julie Byerley, M.D., M.P.H., will serve as the new president and dean of the Geisinger Commonwealth School of Medicine (GCSOM), executive vice president and chief academic officer, effective January 1, 2022. She succeeds Steven Scheinman, M.D., who has served as the president and dean of the college since 2012. Scheinman is set to retire at the end of this year.  

"I am thrilled to announce Julie Byerley as our school's next president and dean," said Jaewon Ryu, M.D., J.D., president and CEO of Geisinger. "In addition to being a highly respected leader in education and her many career accomplishments, Dr. Byerley's passion for academic excellence, research, and teaching will be critical to helping us realize our vision: to make better health easier for the communities we serve. We couldn't be more excited to have her join our team and lead GCSOM into the future."

"We're confident Dr. Byerley will work to assure the quality of GCSOM's educational programs and accreditation that will not only ground students with the very best in healthcare education, research and innovation, but will instill her passion for patient outcomes that will ultimately benefit our communities for generations to follow," said Virginia McGregor, chair of the GCSOM board. "We want to thank Dr. Scheinman for his leadership throughout the years and vision in growing GCSOM from a small community institution into the nationally respected medical school it is today. We look forward to working with Dr. Byerley to continue this tradition of excellence at GCSOM and to build upon the foundation that Dr. Scheinman helped us establish."

"I'm honored and ecstatic to be joining as the new president and dean of GCSOM and Geisinger's chief academic officer," said Dr. Byerley. "The school has a well-known national reputation for being innovative, community centric and patient focused while providing hands-on education and training that prepares students for careers in healthcare. And our research institution has long been recognized as one of the most groundbreaking teams in medicine utilizing population and patient-based data. I am eager to serve and work closely with students, staff, researchers and faculty to further the success of the school, our research environment and all of the academic and training programs that we offer to make better health easier for everyone our students, alumni and researchers will impact throughout their careers."

As the new dean, Byerley will provide visionary leadership for GCSOM, assuring excellence, innovation, and a focus on learners, patients, and the promotion of health. She will continue to establish GCSOM as a leader in the industry and model the community service mission of the organization.

In addition to her GCSOM responsibilities, as chief academic officer, Dr. Byerley will leverage her experience from a world-class academic and research institution at the University of North Carolina (UNC) to also oversee the management of educational experiences for learners throughout Geisinger, including graduate medical education, nursing, pharmacy, advanced practitioners and other health professions.

She will also be responsible for overseeing Geisinger's world-renowned research environment that includes more than 50 full-time research faculty and more than 30 clinician investigators responsible for groundbreaking medical advancements like the MyCode Precision Health Initiative and more. Geisinger's areas of research expertise span precision health, genomics, informatics, data science, implementation science, outcomes research, health services research, bioethics and participation in hundreds of clinical trials each year.

Byerley has been with the UNC School of Medicine since 2002, serving recently as vice dean for academic affairs where she oversaw the school's educational enterprise and the Office of Faculty Affairs and Leadership Development. Since January 2021 she has served as interim dean of the UNC Adams School of Dentistry.

Byerley earned her bachelor's degree in physics and a teaching certificate from Rhodes College and attended medical school at Duke University. She completed her pediatrics residency and chief residency at UNC-Chapel Hill where she also earned a master's degree in public health with a focus on maternal and child health. 

About Geisinger Commonwealth School of Medicine
Geisinger Commonwealth School of Medicine (Geisinger Commonwealth) is a member of the Geisinger family. Geisinger Commonwealth offers a community-based model of medical education with campuses in Atlantic City, Danville, Doylestown, Sayre, Scranton and Wilkes- Barre. Geisinger Commonwealth offers Doctor of Medicine (MD), Master of Biomedical Sciences (MBS) and Professional Science Master's (PSM) degrees. The school's innovative curriculum, focused on caring for people in the context of their lives and their community, attracts the next generation of physicians and scientists from within its region, as well as from across the nation. The school also has more than 500 residents and fellows in 31 accredited residency programs and 27 accredited fellowships. Geisinger Commonwealth is committed to non-discrimination in all employment and educational opportunities. For more information, visit www.geisinger.edu/gcsom, or connect with us on FacebookInstagramLinkedIn and Twitter.

About Geisinger
Geisinger is committed to making better health easier for the more than 1 million people it serves. Founded more than 100 years ago by Abigail Geisinger, the system now includes nine hospital campuses, a health plan with more than half a million members, two research centers and the Geisinger Commonwealth School of Medicine. With nearly 24,000 employees and more than 1,600 employed physicians, Geisinger boosts its hometown economies in Pennsylvania by billions of dollars annually. Learn more at www.geisinger.org, or connect with us on Facebook, Instagram, LinkedIn and Twitter.

CONTACT: Natalie Buyny, 717-357-0345
[email protected] 

SOURCE Geisinger


These press releases may also interest you

at 06:15
The "Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and Customization. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Exciting technical...

at 06:10
Confo Therapeutics, a leader in the discovery of novel medicines targeting G-protein coupled receptors (GPCRs), announced today that it has been awarded a EUR 1.6 million grant from Flanders Innovation & Entrepreneurship (VLAIO). The 2-year grant...

at 06:08
Aesthetic Management Partners LLC, a manufacturer of skin-based solutions and a provider of energy-based devices announces its collaboration with Croma (Croma-Pharma® GmbH), a global player in the minimally invasive aesthetics market and a leading...

at 06:05
The 2023 U.S. soybean field trials conducted by Texas Crop Science (TCS) demonstrated an average yield increase of 21% in soybean lines incorporating the TCS yield trait. This breakthrough in performance would generate approximately $121 per acre in...

at 06:05
3EO Health, a "Point of Life" diagnostics company focused on the development of high-performing low-cost molecular diagnostics, is excited to announce the next step in their quest to make molecular testing affordable. Today, the company has published...

at 06:05
Zura Bio Limited ("Zura Bio") a clinical-stage immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today reported full year 2023 financial results and recent business highlights. The Company has also...



News published on and distributed by: